基因面板市场规模、份额、成长分析、按产品/服务、按方法、按设计、按地区 - 行业预测，2024-2031 年

2022年全球基因panel市场规模为24亿美元，从2023年的28.6亿美元成长到2031年的117.5亿美元，复合年增长率预计将成长19.30%。

个人化医疗和基因技术的快速发展正在显着推动全球基因组市场的成长。随着基因组序列测定成本的下降，基因组变得越来越便宜，从而能够对多种疾病进行全面的基因检测和分析。遗传疾病盛行率的上升以及对精确和客製化治疗策略的需求不断增长正在推动这一市场的扩张。基因组提供了有关遗传倾向和潜在治疗途径的重要见解，增强了在研究、诊断和治疗开发中的应用。这些面板由大量分析的精选基因集合组成，用于检测与各种疾病相关的遗传变异，从而可以同时高效且有针对性地询问多个基因。这种能力不仅有助于揭示遗传疾病，而且有助于制定量身定制的治疗计划。在生物资讯学和定序技术持续创新的推动下，基因组的未来看起来充满希望，预计这些技术将提高其准确性并扩大其临床效用。随着基因组越来越多地融入标准临床实践并扩大用于治疗和预防，其在个人化医疗领域的重要性不断增长，这将为医疗保健领域的开发和应用带来重大机会。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特分析与影响
  • 竞争公司之间的敌对关係
  • 替代品的威胁
  • 买方议价能力
  • 新进入者的威胁
  • 供应商的议价能力

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 技术进步
• 监管环境
• 专利分析
• 价值链分析
• 案例研究分析
• PESTEL分析
• 总体经济指标
• 价格分析

基因组市场：依产品/服务分类

• 检测套组
• 检验服务

基因组市场：依方法论

• 基于扩增子的方法
• 基于混合的方法

基因组市场：依设计设计

• 预先设计的基因组
• 客製化基因panel

基因组市场：依应用分类

• 癌症风险评估
  • 特定综合症
  • 高渗透性
  • 高、中渗透率
  • 整体癌症风险
• 先天性疾病的诊断
• 药物基因学
• 其他用途

基因组市场：依最终用途分类

• 研究/学术机构
• 医院和诊断实验室
• 製药和生物技术公司

基因组市场规模：按地区划分

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Qiagen
• Roche
• Illumina
• Thermo Fisher Scientific
• Agilent Technologies
• Bio-Rad Laboratories
• PerkinElmer
• Becton, Dickinson and Company（BD）
• Sangamo Therapeutics

Global Gene Panel Market size was valued at USD 2.40 Billion in 2022 poised to grow from USD 2.86 Billion in 2023 to USD 11.75 Billion by 2031, growing at a CAGR of 19.30% in the forecast period (2024-2031).

The rapid advancements in personalized medicine and genetic technologies are significantly driving the growth of the global gene panel market. As genomic sequencing costs decline, gene panels have become increasingly affordable, enabling comprehensive genetic testing and analysis for a wide range of diseases. The rising prevalence of hereditary conditions and the growing demand for precise, tailored treatment strategies fuel this market expansion. Gene panels provide critical insights into genetic predispositions and potential treatment pathways, enhancing their application in research, diagnostics, and therapeutic development. These panels consist of a curated collection of genes analyzed collectively to detect genetic variations associated with various disorders, allowing for efficient and targeted investigations of multiple genes simultaneously. This capability not only elucidates hereditary diseases but also fosters the creation of customized treatment plans. The future of gene panels appears promising, bolstered by ongoing innovations in bioinformatics and sequencing technologies that are expected to enhance their accuracy and broaden their clinical utility. As gene panels become increasingly integrated into standard clinical practice and expand their use in both therapeutic and preventive contexts, their significance in the realm of personalized medicine will continue to grow, presenting vast opportunities for development and application in the healthcare sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Gene Panel market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Gene Panel Market Segmental Analysis

Global Gene Panel Market is segmented by Product and Services, Technique, Design, Application, End User and Region. Based on Product and Services, the market is segmented into Test Kits, and Testing Services. Based on Technique, the market is segmented into Amplicon-based Approach, and Hybridization-based Approach. Based on Design the market is segmented into Predesigned Gene Panel, and Customized Gene Panel. Based on Application, the market is segmented into Cancer Risk Assessment, Diagnosis of Congenital Diseases, and Pharmacogenetics. Based on end user, the market is segmented into Research and Academic Institutes, Hospital and Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Gene Panel Market

The global gene panel market is significantly propelled by advancements in next-generation sequencing (NGS) technologies, which enhance precision, speed, and cost-efficiency in genetic analyses. These innovations facilitate comprehensive genomic profiling, thereby enabling personalized medicine tailored to individual genetic profiles. As healthcare increasingly shifts towards targeted therapies and precision diagnostics, the demand for gene panels in both clinical and research settings is rising sharply. Additionally, the ability of NGS to process large amounts of genetic information quickly allows for more effective disease diagnosis and treatment plans, further fueling market growth and attracting investments in genetic research and healthcare innovations.

Restraints in the Global Gene Panel Market

A significant restraint for the global gene panel market is the limited knowledge and understanding among healthcare professionals and patients regarding gene panel testing. Many individuals may not be aware of the advantages and applications of DNA panels, which can hinder their willingness to pursue genetic testing. This lack of education can result in skepticism or misconceptions about the value and utility of gene panels, ultimately slowing down adoption rates. Consequently, the limited awareness diminishes the perceived benefits of genetic testing, thus affecting market expansion and stifling the potential advancements that gene panel technology could offer in personalized medicine and tailored healthcare solutions.

Market Trends of the Global Gene Panel Market

The global gene panel market is experiencing significant growth driven by a marked surge in the adoption of personalized medicine. As healthcare practitioners increasingly leverage gene panels for tailored treatment regimens, this trend emphasizes the importance of precision diagnostics and targeted therapies. Advancements in genomics, particularly in next-generation sequencing technologies, have played a pivotal role in enhancing the accuracy and efficiency of genetic testing, enabling clinicians to make more informed decisions about patient care. Consequently, this shift towards personalized healthcare is not only improving patient health outcomes but also catalyzing demand for innovative gene panel products, positioning the market for substantial expansion.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Value Chain Analysis
• Case Study Analysis
• PESTEL Analysis
• Macro-Economic Indicators
• Pricing Analysis

Global Gene Panel Market Size by Product and Service & CAGR (2024-2031)

• Test Kits
• Testing Services

Global Gene Panel Market Size by Technique & CAGR (2024-2031)

• Amplicon-based Approach
• Hybridization-based Approach

Global Gene Panel Market Size byDesign & CAGR (2024-2031)

• Predesigned Gene Panel
• Customized Gene Panel

Global Gene Panel Market Size byApplication & CAGR (2024-2031)

• Cancer Risk Assessment
  • Syndrome-specific
  • High-penetrance
  • High and Moderate-penetrance
  • Comprehensive Cancer Risk
• Diagnosis of Congenital Diseases
• Pharmacogenetics
• Other Applications

Global Gene Panel Market Size by End-use & CAGR (2024-2031)

• Research and Academic Institutes
• Hospital and Diagnostic Laboratories
• Pharmaceutical and Biotechnology Companies

Global Gene Panel Market Size & CAGR (2024-2031)

• North America, (Product and Services, Technique, Design, Application, End User)
  • US
  • Canada
• Europe, (Product and Services, Technique, Design, Application, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Product and Services, Technique, Design, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Product and Services, Technique, Design, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Product and Services, Technique, Design, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Qiagen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sangamo Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates